Intervention

Dalpicilib

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting1

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast CancerNCT06637150 · 2025-01-09

Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.NCT06500247 · 2024-07-31

NOT_YET_RECRUITING

Common conditions

Breast Cancer1 The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer1

Leading sponsors

Fudan University1 Qilu Hospital of Shandong University1

Trial status mix

NOT_YET_RECRUITING1

RECRUITING1

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.